FEMSEPT 50 micrograms/24 hours, medicated transdermal patch 4 patches in individual sachets
Active ingredients: Estradiol hemihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Medicated transdermal patch4 patches in individual sachetstransdermique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FEMSEPT 50 microgrammes/24 heures, dispositif transdermique
- Pharmaceutical form
- dispositif
- Route of administration
- transdermique
- Presentation description
- 4 sachet(s) aluminium polyéthylène papier P-A-M-éthylène (SURLYN) de 1 dispositif(s)
- Marketing authorisation holder
- THERAMEX IRELAND (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Oct 1998
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65001897CIP73461078CIP133400934610783Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ESTRADIOL HÉMIHYDRATÉdispositif | 1,5 mg · un dispositif | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.